18F-FDG PET图像生物标志物改善晚期放射性口干预测
本研究纳入161例头颈癌患者,从治疗前18F-FDG PET图像提取腮腺强度和纹理PET图像生物标志物(PET-IBM),采用多变量逻辑回归建模并通过自举法内部验证。结果显示高强度PET-IBM(P90)和高纹理PET-IBM(LRHG3E)与12个月放射性口干(Xer12m)风险降低显著相关,且均显著改善参考模型的预测性能,AUC从0.73提升至0.77。
要点
- 腮腺PET-IBM高值与12个月放射性口干风险降低显著相关。
- PET-IBM加入腮腺剂量和基线口干参考模型后AUC从0.73升至0.77。
- 治疗前PET代谢特征有望纳入NTCP模型开发。
核心结论
- 治疗前PET-IBM显著改善12个月放射性口干的预测,提示腮腺高代谢活动与晚期口干风险降低相关。
研究设计与样本
- 从161例头颈癌患者治疗前18F-FDG PET图像提取腮腺强度和纹理PET-IBM,前瞻性收集患者报告毒性。
- 采用逐步前向选择和Lasso正则化的多变量逻辑回归建模,并通过自举法进行内部验证。
主要发现
- 高强度PET-IBM(P90)和高纹理PET-IBM(LRHG3E)高值与Xer12m风险降低显著相关。
- 两种PET-IBM均显著增加参考模型对Xer12m的预测能力。
关键数值与推荐
- 参考模型基于腮腺平均剂量和基线口干(Xerbaseline)评分。
- PET-IBM模型在参考模型基础上分别加入P90或LRHG3E。
临床怎么用
- 可将治疗前18F-FDG PET提取的腮腺PET-IBM纳入NTCP模型,辅助预测晚期口干风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Current prediction of radiation-induced xerostomia 12months after radiotherapy (Xer12m) is based on mean parotid gland dose and baseline xerostomia (Xerbaseline) scores. The hypothesis of this study was that prediction of Xer12m is improved with patient-specific characteristics extracted from 18F-FDG PET images, quantified in PET image biomarkers (PET-IBMs). PATIENTS AND METHODS: Intensity and textural PET-IBMs of the parotid gland were collected from pre-treatment 18F-FDG PET images of 161 head and neck cancer patients. Patient-rated toxicity was prospectively collected. Multivariable logistic regression models resulting from step-wise forward selection and Lasso regularisation were internally validated by bootstrapping. The reference model with parotid gland dose and Xerbaseline was compared with the resulting PET-IBM models. RESULTS: High values of the intensity PET-IBM (90th percentile (P90)) and textural PET-IBM (Long Run High Grey-level Emphasis 3 (LRHG3E)) were significantly associated with lower risk of Xer12m. Both PET-IBMs significantly added in the prediction of Xer12m to the reference model. The AUC increased from 0.73 (0.65-0.81) (reference model) to 0.77 (0.70-0.84) (P90) and 0.77 (0.69-0.84) (LRHG3E). CONCLUSION: Prediction of Xer12m was significantly improved with pre-treatment PET-IBMs, indicating that high metabolic parotid gland activity is associated with lower risk of developing late xerostomia. This study highlights the potential of incorporating patient-specific PET-derived functional characteristics into NTCP model development.
引用
- van Dijk LV, Noordzij W, Brouwer CL, et al. 18F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol. 2017. PMID: 28951007. doi:10.1016/j.radonc.2017.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。